✦ LIBER ✦

Effect of 5-benzylacyclouridine, a potent inhibitor of uridine phosphorylase, on the metabolism of circulating uridine by the isolated rat liver

✍ Scribed by Anne Monks; Ovella Ayers; Richard L. Cysyk

Book ID: 115777053
Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 751 KB
Volume: 32
Category: Article
ISSN: 0006-2952
DOI: 10.1016/0006-2952(83)90419-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of 5-benzylacyclouridine, an inh

Effects of 5-benzylacyclouridine, an inhibitor of uridine phosphorylase, on the pharmacokinetics of uridine in rhesus monkeys: implications for chemotherapy

✍ Jean-Pierre Sommadossi; Erika M. Cretton; Lauren B. Kidd; Harold M. McClure; Dan 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 966 KB

Use of oral uridine as a substitute for

Use of oral uridine as a substitute for parenteral uridine rescue of 5-fluorouracil therapy, with and without the uridine phosphorylase inhibitor 5-benzylacyclouridine

✍ Daniel S. Martin; Robert L. Stolfi; Robert C. Sawyer 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 625 KB

19F NMR monitoring of in vivo tumor meta

19F NMR monitoring of in vivo tumor metabolism after biochemical modulation of 5-fluorouracil by the uridine phosphorylase inhibitor 5-benzylacyclouridine

✍ Scott K. Holland; Andries M. Bergman; Yiming Zhao; Earle R. Adams; Giuseppe Pizz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 1014 KB

## Abstract A uridine phosphorylase inhibitor, 5‐benzylacyclouridine (BAU), has been utilized as biochemical modulator of 5‐fluorouracil (5‐FU) anti‐tumor activity in a murine tumor model. The effect of BAU on 5‐FU metabolism has been evaluated using __in vitro__ and __in vivo__ ^19^F NMR spectrosc

Degradation of uridine by the isolated p

Degradation of uridine by the isolated perfused rat liver

✍ Holstege, A.; Pausch, J.; Gengenbacher, H.-M.; Häussinger, D.; Gerok, W. 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Modulation of the pharmacokinetics of en

Modulation of the pharmacokinetics of endogenous plasma uridine by 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for chemotherapy

✍ Omar N. Al Safarjalani; Xiao-Jian Zhou; Fardos N. Naguib; Naganna M. Goudgaon; R 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 111 KB

Enhancement of the bioavailability of or

Enhancement of the bioavailability of oral uridine by coadministration of 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for uridine rescue regimens in chemotherapy

✍ Omar N. Safarjalani; Xiao-Jian Zhou; Fardos N. Naguib; Junxing Shi; Raymond F. S 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 182 KB